Inhibikase Therapeutics, Inc.盘中异动股价大跌5.11%

市场透视10-30

北京时间2024年10月30日02时36分，Inhibikase Therapeutics, Inc.（IKT.us）股票出现异动，股价急速下挫5.11%。截至发稿，该股报2.60美元/股，成交量14.2958万股，换手率0.22%，振幅6.39%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.96百万美元，每股收益-0.66美元，毛利-6569.00美元，市盈率-0.81倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2479025810?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-30 02:36","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2479025810","market":"us","top_or_hot":-1,"title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.11%","media":"市场透视","content":"<div>\n<p>北京时间2024年10月30日02时36分，Inhibikase Therapeutics, Inc.（IKT.us）股票出现异动，股价急速下挫5.11%。截至发稿，该股报2.60美元/股，成交量14.2958万股，换手率0.22%，振幅6.39%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.96百万美元，每股收益-0.66美元，毛利-6569.00美元，市盈率-0.81倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030023625971a2fec&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInhibikase Therapeutics, Inc.盘中异动 股价大跌5.11%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-30 02:36 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030023625971a2fec&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月30日02时36分，Inhibikase Therapeutics, Inc.（IKT.us）股票出现异动，股价急速下挫5.11%。截至发稿，该股报2.60美元/股，成交量14.2958万股，换手率0.22%，振幅6.39%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.96百万美元，每股收益-0.66美元，毛利-6569.00美元，市盈率-0.81倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030023625971a2fec&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IKT","symbol_name":"Inhibikase Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030023625971a2fec&s=b","article_id":"2479025810","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030023625971a2fec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2479025810","pubTimestamp":1730226985,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月30日02时36分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速下挫5.11%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IKT":"Inhibikase Therapeutics, Inc.","BK4139":"生物科技","LENZ":"Therapeutics"},"translate_title":"Inhibikase Therapeutics, Inc. stock plunges 5.11% during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IKT":1,"LENZ":1},"content_text":"北京时间2024年10月30日02时36分，Inhibikase Therapeutics, Inc.（IKT.us）股票出现异动，股价急速下挫5.11%。截至发稿，该股报2.60美元/股，成交量14.2958万股，换手率0.22%，振幅6.39%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.96百万美元，每股收益-0.66美元，毛利-6569.00美元，市盈率-0.81倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028(To Pur Com)、Dermata Therapeutics Inc C/Wts (To Pur Com)涨幅较大，Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1577.69%、1392.43%、350.75%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts (01/12/2026) To Pur Com、Dermata Therapeutics Inc C/Wts (To Pur Com)，振幅分别为183.65%、88.24%、78.31%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病（PD），帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。其多治疗产品线主要关注神经退行性疾病，其项目利用 Risvodetinib（也称为 IkT-148009），一种非受体 Abelson 酪氨酸激酶的选择性抑制剂，也针对大脑内部和外部的帕金森病的治疗以及由阿贝尔森酪氨酸激酶引起的其他疾病。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2479025810"}

Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.11%

精彩评论

Inhibikase Therapeutics, Inc.盘中异动股价大跌5.11%